This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder
British Journal of Cancer Open Access 29 January 1999
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Paul, W.E. J. Immun. 139, 1–6 (1987).
Poo, W.J., Conrad, L. & Janeway, C.A. Jr Nature 332, 378–380 (1988).
Schwartz, R.H. A. Rev. Immun. 3, 237–261 (1985).
Babbitt, B. et al. Nature 317, 359–361 (1985).
Kelly, R.B. Science 230, 25–32 (1985).
Burgess, T.L. & Kelly, R.B. A. Rev. Cell Biol. 3, 243 (1987).
Lawson, D. et al. J. Cell Biol. 79, 394–400 (1978).
Geiger, B. et al. J. Cell Biol. 95, 137–143 (1982).
Kupfer, A., Singer, S.J. & Dennert, G. J. exp. Med. 163, 489–498 (1986).
Kupfer, A. et al. Proc. natn. Acad. Sci. U.S.A. 83, 6080–6083 (1986).
Virtanen, I. Eur. J. Cell Biol. 42, 281–287 (1986).
Durum, S.K., Schmidt, J.A. & Oppenheim, J. J. A. Rev. Immun. 3, 263–287 (1985).
De Franco, A., Ashwell, J.D., Schwartz, R.H. & Paul, W.E. J. exp. Med. 159, 861–880 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sitkovsky, M., Paul, W. Global or directed exocytosis?. Nature 332, 306–307 (1988). https://doi.org/10.1038/332306a0
Issue Date:
DOI: https://doi.org/10.1038/332306a0
This article is cited by
-
Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
Journal of Molecular Medicine (2014)
-
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
Journal of Molecular Medicine (2013)
-
Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder
British Journal of Cancer (1999)
-
Intratumoral interleukin-2 immunotherapy: Activation of tumor-infiltrating and splenic lymphocytes in vivo
Cancer Immunology Immunotherapy (1993)